You are on page 1of 8

SRI LANKA EQUITY | BANKS

EARNINGS UPDATE | 05 MARCH 2021

Commercial Bnk.[COMB]:BUY [+33%] Kavinda Perera


kavinda@asiasecurities.lk
+94 11 772 2044
Strong NII momentum & lower CoR to drive earnings
We increase our TP for COMB to LKR 105.00/share (+5.0% to old; +24.3% Key statistics Voting | Non-voting
upside; +32.5% TSR) and for COMBX to LKR 87.00/share (+4.8% to old; BBG ticker COMB SL | COMBX SL
+11.3% upside; +20.2% TSR). We maintain BUY for both classes. PAT in 4Q CSE ticker COMB.N0000 | COMB.X0000
CY20 was flat YoY (+59.0% QoQ) which came on the back of a strong NII GICS subsector Diversified Banks
growth reflecting robust CASA, coupled with faster deposit repricing. Along
Price at 04 Mar 21 (LKR) 84.50 | 78.20
with this, we expect NIMs to improve in CY21E, albeit modestly, and mainly
100.75/48.95
in 2H. Loan growth in CY20 was 3.3% YoY, and with the expected economic 52 week Hi/Lo (LKR)
|89.90/48.44
recovery, we increase our CY21E forecast to 10.0% (vs. 7.0% previously). Market cap (LKR mn) 98,175
IFC’s LKR 10bn injection has strengthened COMB’s capital position which is Market cap (USD mn) 517
a positive in the current environment. Long-term BUY rating on extremely No. of shares (mn) 1,099 | 68
weak valuations (both classes at 0.6x CY21E BV with an ROE of 12.6%).
ADT (LKR mn) - 3M 110.1 | 8.8
ADT (USD k) - 3M 579.7 | 46.2
Strong NII growth supported by lower cost of funds; NIMs to pickup in CY21E
Net profit in 4Q CY20 was flat YoY (+59.0% QoQ), backed by a strong Net ADT (shares k) – 3M 1,224 | 110.4
interest income (NII) performance and trading and FX gains. NII grew 17.9% YoY Free float (%) 58.2 | 73.7
(+0.3% QoQ) driven mainly by strong deposit repricing and a robust CASA base, Public float (%) 99.8 | 99.9
where ~70.0% of incremental deposits in CY20 came through CASA. With 1) Company website | CSE website
strong loan book growth and 2) interest rates gradually picking up, we expect Source: CSE, Bloomberg, Company data
NIMs to see a pickup in CY21E (+20bps YoY). Note: LKR converted at 190 LKR per USD

Impairment charges elevated in 4Q; CoR to trend down gradually in CY21E Valuation summary Voting | Non-voting
COMB booked impairment charges of LKR 4.7bn in 4Q CY20, closing CY20 with Price at 04 Mar 21 (LKR) 84.50 78.20
LKR 21.4bn in total impairments. G-Sec related impairments (given the Target price (LKR) 105.00 87.00
Sovereign downgrade) and booking additional prudential impairments for some
Upside (%) +24.3 +11.3
of the risk sectors drove this. While the 4Q charge was 37.2% lower than the
CY21E DPS (LKR)* 7.00 7.00
historically high 3Q, we note that CY20 Cost of Risk (CoR) was 227bps – one of
the highest in history, and we believe that the current risk factors are Total return (%) +32.5 +20.2
adequately reflected in the provisioning. Bank’s NPL stock dropped 0.5% QoQ, Source: Asia Securities |*incl. scrip dividend
and in line with our sector view, we expect NPLs and impairment charges to
Share price movement (indexed to COMB)
gradually taper down in CY21E, with CoR reducing to 120bps.
LKR
CY20 closes with soft loan growth, but we raise our CY21E estimate 130
Gross loans grew 1.3% QoQ in 4Q CY20, leading to the loan book expanding 3.3%
YoY in CY20. Management noted that SME loan demand is still concentrated 110
around working capital and short-term financing, while we expect investment-
90
led borrowing would see some pick up from 2H CY21E. We upgrade our loan
growth forecast to 10.0% for CY21E from 7.0% previously. 70

Our TP for COMB moves to LKR 105.00/share and COMBX to LKR 87.00/share 50
We maintain our expectation that CY21E will see a recovery in credit growth Mar-20 Jul-20 Nov-20 Mar-21
and asset quality, albeit back-end loaded. Both COMB and COMBX trades at COMB COMBX
0.6x BV CY21E with an ROE of 12.6%. While some of the residual macro risk ASPI S&P SL20
factors continue to weigh on the banking sector valuations, we note that the Movement (%) YTD 3M 12M
current valuations are attractive for a long-term play. With our estimate COMB 4 3 2
changes, our TP increases for COMB to LKR 105.00/share (+5.0% to old; +24.3%
ASPI 3 9 26
upside; +32.5% TSR) and for COMBX to LKR 87.00/share (+4.8% to old; +11.3%
S&P SL20 5 9 7
upside; +20.2% TSR). Both classes BUY.
Source: CSE, Bloomberg
Financial summary
In LKR mn 4Q CY19 4Q CY20 YoY % CY20 CY21E YoY %
Net interest income 11,933 14,073 +17.9 50,869 56,569 +11.2
Pre-impairment income 10,805 14,282 +32.2 50,467 46,219 -8.4
Recurring net profit 5,865 5,873 +0.1 16,940 20,472 +20.9
Gross loans and advances 930,737 961,859 +3.3 961,859 1,058,045 +10.0
Recurring diluted EPS (LKR) 5.58 5.44 -2.5 15.70 17.28 +10.0
ROE (%) 13.6 11.5 -2.1pp 11.5 12.6 +1.1pp
P/E (x) 5.4 5.9 6.2 4.9
P/B (x) 0.7 0.6 0.7 0.6
Source: Company data, Asia Securities | Note: Historical interim ROE, P/E on a TTM basis
1
This report is strictly for direct recipients from Asia Securities. Redistribution of this report is prohibited. Please see page 6 for analyst &
company certification and important disclosure.
Estimate review & revisions
In LKR mn CY20 E CY20 A % var CY21E - O CY21E – N %Δ CY22E - O CY22E – N %Δ
Net interest income 49,335 50,869 +3.1 56,387 56,569 +0.3 61,350 59,944 -2.3
Pre-impairment income 45,381 50,467 +11.2 44,204 46,219 +4.6 47,924 47,750 -0.4
Recurring net profit 15,118 16,940 +12.1 18,406 20,472 +11.2 21,309 22,154 +4.0
Gross loans and advances 957,577 961,859 +0.4 1,024,607 1,058,045 +3.3 1,127,068 1,163,850 +3.3
Recurring diluted EPS (LKR) 13.47 15.70 +16.6 14.84 17.28 +16.4 16.56 18.18 +9.8
Tan. BVPS (LKR) 122.71 134.88 +9.9 127.73 136.13 +6.6 130.97 140.03 +6.9
ROE (%) 10.6 11.5 +0.9pp 11.7 12.6 +0.9pp 12.6 13.0 +0.4pp
P/E (x) 5.7 6.2 5.1 4.9 4.6 4.6
P/B (x) 0.6 0.7 0.6 0.6 0.6 0.6
Source: Company data, Asia Securities | Note: O – Old estimate, N – New estimate

Key ratios
CY2018 CY2019 CY2020 CY2021E CY2022E CY2023E
Recurring net income growth (%) 6.8 (2.7) (1.9) 20.9 8.2 6.2
Diluted recurring EPS growth (%) 5.3 (6.5) (4.3) 10.0 5.2 3.6
Loan growth (%) 18.1 3.7 3.3 10.0 10.0 8.0
Gross NPL (%) 3.24 4.95 5.11 4.80 4.20 3.80
Net NPL (%) 1.71 3.00 2.18 2.05 1.79 1.62
NIM (%) 4.23 3.96 3.51 3.70 3.83 3.90
NIS (%) 4.3 3.8 3.1 3.4 3.5 3.5
Cost/income (%) 36.8 38.6 34.2 40.3 40.9 41.4
CASA (%) 38.0 37.6 42.9 43.5 42.5 38.0
Loans/deposits (%) 90.3 87.1 74.8 82.0 85.0 90.0

Tier 1 ratio (%) 11.14 12.30 13.22 12.99 12.49 13.57


Total capital ratio (%) 15.33 16.15 16.82 16.68 16.34 17.55

ROA (%) 1.4 1.3 1.1 1.2 1.2 1.2


ROE (%) 15.6 13.6 11.5 12.6 13.0 12.3
P/E (x) 7.2 5.1 6.2 4.9 4.6 4.5
P/B (x) 1.1 0.6 0.7 0.6 0.6 0.5
Dividend yield (%)* 5.1 7.8 6.7 8.3 8.9 8.9
Dividend payout (%)* 37.0 39.6 41.4 40.5 41.3 39.8

Recurring diluted EPS (LKR) 17.55 16.41 15.70 17.28 18.18 18.82
DPS (LKR) 6.50 6.50 6.50 7.00 7.50 7.50
Tan. BVPS (LKR) 116.71 129.22 134.88 136.13 140.03 161.83

No. of employees 5,027 5,062 5,057 5,042 5,027 5,012


No. of branches 285 287 287 287 287 287
Source: Company data, Asia Securities | Note: *Dividend yield and Dividend payout include both cash and scrip dividends

2
This report is strictly for direct recipients from Asia Securities. Redistribution of this report is prohibited. Please see page 6 for analyst &
company certification and important disclosure.
Income statement
In LKR mn CY2018 CY2019 CY2020 CY2021E CY2022E CY2023E
Net interest income 45,618 48,356 50,869 56,569 59,944 64,824
Net fee and commission income 10,634 10,752 9,822 10,313 11,550 12,936
Net FX income (3,122) 1,079 - - - -
Net trading income 89 282 1,878 1,972 2,071 2,174
Net investment income 272 1,136 6,390 2,341 2,208 2,221
Total non-interest income 7,873 13,248 18,090 14,625 15,829 17,332
Other operating income 11,373 6,082 7,771 6,217 5,595 5,035
Total income 64,864 67,687 76,729 77,411 81,367 87,192
Personnel expenses (13,290) (14,409) (14,993) (17,207) (18,528) (19,950)
Depreciation and amortization (1,603) (2,841) (3,103) (3,534) (3,698) (3,952)
Other expenses (8,994) (8,875) (8,167) (10,450) (11,391) (12,207)
Total operating expenses (23,887) (26,125) (26,263) (31,192) (33,617) (36,109)
Pre-impairment income 40,978 41,561 50,467 46,219 47,750 51,083
Net impairment charge (8,833) (11,332) (21,420) (13,022) (11,825) (12,919)
Operating profit before VAT and NBT 32,144 30,230 29,047 33,197 35,925 38,164
VAT and NBT (6,052) (7,256) (4,531) (5,312) (5,748) (6,106)
Associate income (pre-tax) - - - - - -
Profit before tax 26,093 22,974 24,516 27,885 30,177 32,057
Income tax expense (8,236) (5,564) (7,433) (7,250) (7,846) (8,335)
Associate income (post-tax) 6 10 4 4 4 4
Minority interest (128) (157) (147) (167) (181) (192)
Recurring net income 17,735 17,263 16,940 20,472 22,154 23,534
Source: Company data, Asia Securities

3
This report is strictly for direct recipients from Asia Securities. Redistribution of this report is prohibited. Please see page 6 for analyst &
company certification and important disclosure.
Balance sheet
In LKR mn CY2018 CY2019 CY2020 CY2021E CY2022E CY2023E
Assets
Cash and cash equivalent 44,356 53,681 51,255 51,402 54,546 55,637
Balances with Central Banks 55,407 46,101 115,359 115,359 115,359 115,359
Placements with banks 19,899 24,904 16,422 16,750 17,085 17,427
Reverse repurchase agreements 9,514 13,148 - - - -
Derivative financial assets 7,910 1,831 2,637 2,637 2,637 2,637
Financial investments - FVTPL 5,520 21,468 35,189 28,152 16,891 11,824
Financial investments - FVOCI 176,761 197,825 278,717 209,038 199,643 199,643
Financial investments - HTM - - - - - -
Financial investments – Debt & Other 89,274 107,059 302,060 317,163 333,021 349,672
Loans and advances 868,375 894,677 910,609 995,107 1,090,906 1,173,256
Equity method investments 105 57 64 64 64 64
Property, plant and equipment 17,015 22,423 25,387 22,852 20,154 17,202
Leasehold property 103 102 - - - -
Intangible assets 1,434 1,646 1,801 1,801 1,801 1,801
Other assets 24,240 24,020 22,998 22,998 22,998 23,458
Total assets 1,319,912 1,408,941 1,762,496 1,783,321 1,875,105 1,967,979

Liabilities
Customer deposits 994,371 1,068,983 1,286,616 1,290,299 1,369,235 1,396,619
Borrowings - Banks 52,362 53,807 88,248 70,598 105,898 116,487
Borrowings - Other 25,362 23,249 54,556 38,189 40,099 46,113
Subordinated debt 37,992 37,887 38,247 30,598 36,717 42,225
Repurchase agreements 48,951 51,117 91,412 137,117 95,982 110,379
Current tax liabilities 6,736 5,197 6,991 7,690 8,459 9,305
Derivative financial liabilities 8,022 1,495 1,501 1,501 1,501 1,501
Other financial liabilities – HFT - - - - - -
Other liabilities 25,519 31,192 33,976 40,277 40,925 36,804
Total liabilities 1,199,315 1,272,928 1,601,547 1,616,270 1,698,816 1,759,435

Equity
Stated capital 39,148 40,917 52,188 54,346 57,901 60,947
Statutory reserves 7,444 8,388 9,285 10,309 11,417 12,593
Retained earnings 4,950 5,182 8,124 6,850 6,541 29,442
Other reserves 67,856 79,937 89,596 94,075 98,779 103,718
Non-controlling interest 1,199 1,589 1,756 1,471 1,652 1,844
Total equity 120,597 136,013 160,949 167,051 176,289 208,544

Total equity and liabilities 1,319,912 1,408,941 1,762,496 1,783,321 1,875,105 1,967,979

Contingent liabilities 658,860 580,962 730,562 739,194 777,238 815,735


Source: Company data, Asia Securities

4
This report is strictly for direct recipients from Asia Securities. Redistribution of this report is prohibited. Please see page 6 for analyst &
company certification and important disclosure.
Top 10 shareholders – Voting (% held)
Shareholder Dec 2019 Sep 2020 Dec 2020 Δ YoY (pp) Δ QoQ (pp)

DFCC Bank PLC A/C 1 13.54 13.43 12.02 -1.52 -1.41

Mr. Y. S. H. I. Silva 8.07 9.70 8.87 +0.80 -0.83

Employees Provident Fund 9.63 9.63 8.62 -1.01 -1.01

CB NY S/A International Finance Corporation 4.44 4.44 7.12 +2.68 +2.68

Sri Lanka Insurance Corporation Ltd. - Life Fund 4.93 6.17 5.59 +0.66 -0.58

Citibank New York S/A Norges Bank Account 2 2.29 4.65 4.16 +1.87 -0.49

Melstacorp PLC 4.62 4.62 4.14 -0.48 -0.48

CB NY S/A IFC Emerging Asia Fund. LP - - 3.67 +3.67 +3.67

CB NY S/A IFC Financial Institutions Growth Fund LP - - 3.67 +3.67 +3.67

Sri Lanka Insurance Corporation Ltd. - General Fund 3.90 3.90 3.54 -0.36 -0.36

Source: Company data

Top 10 shareholders – Non-voting (% held)


Shareholder Dec 2019 Sep 2020 Dec 2020 Δ YoY (pp) Δ QoQ (pp)

Employees Trust Fund Board 7.78 7.78 7.78 - -

Akbar Brothers (Pvt) Ltd. A/C No 1 4.16 4.54 4.59 +0.43 +0.05

Deutsche Bank AG as Trustee to Assetline Income Plus Growth


- 2.60 2.60 +2.60 -
Fund

GF Capital Global Limited 2.59 2.59 2.59 - -

Mr. A. H. Munasinghe - 2.43 2.43 +2.43 -

Mr. M. F. Hashim 1.64 1.89 1.89 +0.25 -

Serendip Investments Limited 2.26 2.11 1.72 -0.54 -0.39

M. J. F. Exports (Pvt) Ltd 1.71 1.71 1.71 - -

Mrs. L. V. C. Samarasinha 1.35 1.51 1.51 +0.16 -

Saboor Chatoor (Pvt) Ltd 1.37 1.39 1.39 +0.02 -

Source: Company data

5
This report is strictly for direct recipients from Asia Securities. Redistribution of this report is prohibited. Please see page 6 for analyst &
company certification and important disclosure.
Analyst Certification
I, Kavinda Perera, certify that the views expressed in this report accurately reflect my
personal views about the company. I also certify that no part of my compensation was, is, or
will be, indirectly or directly, related to the specific view or recommendation expressed in this
report.

Company Certification
Asia Securities (Private) Limited has no direct affiliation with the company/companies covered
in this report and does not receive any material benefit from the company for publishing this
report.

Disclaimer
The report has been prepared by Asia Securities (Private) Limited. The information and
opinions contained herein has been compiled or arrived at based upon information obtained
from sources believed to be reliable and in good faith. Such information has not been
independently verified and no guaranty, representation or warranty, express or implied is
made as to its accuracy, completeness or correctness, reliability or suitability. All such
information and opinions are subject to change without notice. This document is for
information purposes only, descriptions of any company or companies or their securities
mentioned herein are not intended to be complete and this document is not, and should not be
construed as, an offer, or solicitation of an offer, to buy or sell any securities or other
financial instruments. In no event will Asia Securities (Private) Limited be liable for any loss or
damage including without limitation, indirect or consequential loss or damage, or any loss or
damage whatsoever arising out of, or in connection with the use of this report and any reliance
you place on such information is therefore strictly at your own risk.

Asia Securities (Private) Limited may, to the extent permissible by applicable law or
regulation, use the above material, conclusions, research or analysis in which they are based
before the material is disseminated to their customers. Not all customers will receive the
material at the same time. Asia Securities (Private) Limited, their respective directors,
officers, representatives, employees, related persons and/or Asia Securities (Private) Limited,
may have a long or short position in any of the securities or other financial instruments
mentioned or issuers described herein at any time and may make a purchase and/or sale, or
offer to make a purchase and/or sale of any such securities or other financial instruments from
time to time in the open market or otherwise, in each case either as principal or agent. Asia
Securities (Private) Limited may make markets in securities or other financial instruments
described in this publication, in securities of issuers described herein or in securities
underlying or related to such securities. Asia Securities (Private) Limited may have recently
underwritten the securities of an issuer mentioned herein. The information contained in this
report is for general information purposes only. This report and its content is copyright of Asia
Securities (Private) Limited and all rights reserved. This report- in whole or in part- may not,
except with the express written permission of Asia Securities (Private) Limited be reproduced
or distributed or commercially exploited in any material form by any means whether graphic,
electronic, mechanical or any means. Nor may you transmit it or store it in any other website
or other form of electronic retrieval system. Any unauthorized use of this report will result in
immediate proceedings.

6
This report is strictly for direct recipients from Asia Securities. Redistribution of this report is prohibited. Please see page 6 for analyst &
company certification and important disclosure.
RESEARCH DISCLOSURES

Third Party Research

This is third party research. It was prepared by Asia Securities (Pvt) Limited (Asia Securities), with headquarters in Colombo, Sri Lanka. Asia Securities is
authorized to engage in securities activities according to its domestic legislation. This research is not a product of Tellimer Markets, Inc., a U.S.
registered broker-dealer. Asia Securities has sole control over the contents of this research report. Tellimer Markets, Inc. does not exercise any control
over the contents of, or the views expressed in, research reports prepared by Asia Securities.
Asia Securities is not registered as a broker-dealer in the United States and, therefore, is not subject to U.S. rules regarding the preparation of research
reports and the independence of research analysts. This research report is provided for distribution to “major U.S. institutional investors” and other
“U.S. institutional investors” in reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as
amended (the “Exchange Act”).
Any U.S. recipient of this research report wishing to effect any transaction to buy or sell securities or related financial instruments based on the
information provided in this research report should do so only through Tellimer Markets, Inc. located at 575 Fifth Avenue, 27th Floor, New York, NY
10017. A representative of Tellimer Markets, Inc. is contactable on +1 (212) 551 3480. Under no circumstances should any U.S. recipient of this research
report effect any transaction to buy or sell securities or related financial instruments through Asia Securities Tellimer Markets, Inc. accepts
responsibility for the contents of this research report, subject to the terms set out below, to the extent that it is delivered to a U.S. person other than a
major U.S. institutional investor.
None of the materials provided in this report may be used, reproduced, or transmitted, in any form or by any means, electronic or mechanical, including
recording or the use of any information storage and retrieval system, without written permission from.
Asia Securities is the employer of the research analyst(s) responsible for the content of this report and research analysts preparing this report are
resident outside the U.S. and are not associated persons of any U.S. regulated broker-dealer. The analyst whose name appears in this research
report is not registered or qualified as a research analyst with the Financial Industry Regulatory Authority (“FINRA”) and may not be an associated
person of Tellimer Markets, Inc. and, therefore, may not be subject to applicable restrictions under FINRA Rules on communications with a subject
company, public appearances and trading securities held by a research analyst account.
Tellimer Markets, Inc. or its affiliates has not managed or co-managed a public offering of securities for the subject company in the past 12 months, has
not received compensation for investment banking services from the subject company in the past 12 months, and does not expect to receive or intend to
seek compensation for investment banking services from the subject company in the next three months. Tellimer Markets, Inc. has never owned any
class of equity securities of the subject company. There are no other actual, or potential, material conflicts of interest of Tellimer Markets, Inc. at the
time of the publication of this report. As of the publication of this report, Tellimer Markets, Inc. does not make a market in the subject securities.
About Tellimer
Tellimer is a registered trade mark of Exotix Partners LLP. Exotix Partners LLP and its subsidiaries ("Tellimer") provide specialist investment banking
services to trading professionals in the wholesale markets. Tellimer draws together liquidity and matches buyers and sellers so that deals can be
executed by its customers. Tellimer may at any time, hold a trading position in the securities and financial instruments discussed in this report. Tellimer
has procedures in place to identify and manage any potential conflicts of interests that arise in connection with its research. A copy of Tellimer’s
conflict of interest policy is available at www.tellimer.com/regulatory-information.
Distribution
This report is not intended for distribution to the public and may not be reproduced, redistributed or published, in whole or in part, for any purpose
without the written permission of Tellimer. Tellimer shall accept no liability whatsoever for the actions of third parties in this respect. This report is for
distribution only under such circumstances as may be permitted by applicable law.
This report may not be used to create any financial instruments or products or any indices. Neither Tellimer, nor its members, directors,
representatives, or employees accept any liability for any direct or consequential loss or damage arising out of the use of all or any part of the
information herein.

United Kingdom: Distributed by Exotix Partners LLP only to Eligible Counterparties or Professional Clients (as defined in the FCA Handbook). The
information herein does not apply to, and should not be relied upon by, Retail Clients (as defined in the FCA Handbook); neither the FCA’s protection
rules nor compensation scheme may be applied.
UAE: Distributed in the Dubai International Financial Centre by Exotix Partners LLP (Dubai) which is regulated by the Dubai Financial Services Authority
(“DFSA”). Material is intended only for persons who meet the criteria for Professional Clients under the Rules of the DFSA and no other person should act
upon it.
Other distribution: The distribution of this report in other jurisdictions may be restricted by law and persons into whose possession this document
comes should inform themselves about, and observe, any such restriction.
Disclaimers
Tellimer and/or its members, directors or employees may have interests, or long or short positions, and may at any time make purchases or sales as a
principal or agent of the securities referred to herein. Tellimer may rely on information barriers, such as “Chinese Walls” to control the flow of
information within the areas, units, divisions, groups of Tellimer.
Investing in any non-U.S. securities or related financial instruments (including ADRs) discussed in this report may present certain risks. The securities of
non-U.S. issuers may not be registered with, or be subject to the regulations of, the U.S. Securities and Exchange Commission. Information on such non-
U.S. securities or related financial instruments may be limited. Foreign companies may not be subject to audit and reporting standards and regulatory
requirements comparable to those in effect within the United States. The value of any investment or income from any securities or related financial
instruments discussed in this report denominated in a currency other than U.S. dollars is subject to exchange rate fluctuations that may have a positive
or adverse effect on the value of or income from such securities or related financial instruments.
Frontier and Emerging Market laws and regulations governing investments in securities markets may not be sufficiently developed or may be subject to
inconsistent or arbitrary interpretation or application. Frontier and Emerging Market securities are often not issued in physical form and registration of
ownership may not be subject to a centralised system. Registration of ownership of certain types of securities may not be subject to standardised
procedures and may even be effected on an ad hoc basis. The value of investments in Frontier and Emerging Market securities may also be affected by
fluctuations in available currency rates and exchange control regulations. Not all of these or other risks associated with the relevant company, market
or instrument which are the subject matter of the report are necessarily considered.
Research
Kavinda Perera – Head of Research Lakshini Fernando Naveed Majeed
Strategy | Banks | Insurance | Economics | Finance Manufacturing |
Telecommunications lakshini@asiasecurities.lk Energy | Construction
kavinda@asiasecurities.lk +94 11 772 2045 naveed@asiasecurities.lk
+94 11 772 2044 +94 11 772 2043

Harini Wijayaratnam Shevon Mendis Semini Mendis


Leisure | Healthcare Banks Consumer
harini@asiasecurities.lk shevon@asiasecurities.lk semini@asiasecurities.lk
+94 11 772 2042 +94 11 772 2047 +94 11 772 2048

Institutional Sales
Sabri Marikar Shiyam Subaulla Niroshan Wijekoon
Deputy Chairman COO, Equities niroshan@asiasecurities.lk
sabri@asiasecurities.lk shiyam@asiasecurities.lk +94 11 772 2007
+94 11 772 2022 +94 11 772 2011 +94 77 771 3645
+94 77 357 6868 +94 77 350 2016

Dayan Fernando Charith Perera Gagani Jayawardhana


Dayan@asiasecurities.lk charith@asiasecurities.lk gagani@asiasecurities.lk
+94 77 735 4081 +94 11 772 2015 +94 11 772 2014
+94 77 359 8937 +94 71 408 4953

Foreign Sales
Lahiru Ariyaratne Udith Wickramasinghe Jeevan Hettigoda
CEO udith@asiasecurities.lk jeevan@asiasecurities.lk
lahiru@asiasecurities.lk +94 11 772 2031 +94 11 772 2080
+94 11 772 2002 +94 71 868 8004 +94 77 378 2661
+94 77 3468103

Retail Sales
Subeeth Perera Priyantha Hingurage Romesh Priyadarshana
subeeth@asiasecurities.lk priyantha@asiasecurities.lk romesh@asiasecurities.lk
+94 11 772 2035 +94 11 772 2033 +94 11 772 2032
+94 71 404 2683 +94 77 350 2015 +94 77 254 8795

Kalana Hewawasam Ashan Silva Yasith Gallage


kalanag@asiasecurities.lk ashan@asiasecurities.lk Yasith@asiasecurities.lk
+94 11 772 2028 +94 11 772 2005 +94 11 772 2010
+94 77 395 9438 +94 77 045 8028 +94 77 629 4214

Asia Securities (Pvt) Ltd., 4th Floor, Lee Hedges Tower, 349, Galle Road, Colombo 03, Sri Lanka. | Tel: +94 11 772 2000 | Web: www.asiasecurities.net

You might also like